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Highlights 1 
• MEG has a higher sensitivity to SI cortex responses than evoked potentials in FRDA 2 
• Neuromagnetic responses at SI cortex are delayed and reduced in amplitude in FRDA 3 
• Tactile MMN responses at SII cortex are reduced and delayed in FRDA  4 
 5 
 6 
Abstract   7 
Objective: To study using magnetoencephalography (MEG) the spatio-temporal dynamics of 8 
neocortical responses involved in sensory processing and early change detection in Friedreich 9 
ataxia (FRDA).  10 
Methods: Tactile (TERs) and auditory (AERs) evoked responses, and early neocortical 11 
change detection responses indexed by the mismatch negativity (MMN) were recorded using 12 
tactile and auditory oddballs in sixteen FRDA patients and matched healthy subjects. 13 
Correlations between the maximal amplitude of each response, genotype and clinical 14 
parameters were investigated.   15 
Results: Evoked responses were detectable in all FRDA patients but one. In patients, TERs 16 
were delayed and reduced in amplitude, while AERs were only delayed. Only tactile MMN 17 
responses at the contralateral secondary somatosensory cortex were altered in FRDA patients. 18 
Maximal amplitudes of TERs, AERs and tactile MMN correlated with genotype, but did not 19 
correlate with clinical parameters.  20 
Conclusions: In FRDA, the amplitude of tactile MMN responses at SII cortex are reduced and 21 
correlate with the genotype, while auditory MMN responses are not altered. 22 
Significance: Somatosensory pathways and tactile early change detection are selectively 23 
impaired in FRDA. 24 
 25 
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Abbreviations:  4 
AERs: neocortical auditory evoked responses 5 
AI: primary auditory cortex 6 
amMMN: auditory magnetic MMN 7 
aMMN: auditory MMN 8 
cAI: contralateral primary auditory cortex 9 
cSI: contralateral primary auditory cortex 10 
cSII: contralateral secondary somatosensory cortex  11 
cEMFs : cortical evoked magnetic fields  12 
D: Deviants 13 
dSPM: dynamic statistical parametric mapping 14 
ECG: electrocardiogam  15 
EFACTS: European Friedreich's Ataxia Consortium for Translational Studies  16 
EOGs: electrooculograms  17 
FRDA: Friedreich ataxia 18 
FXN: frataxin 19 
ICA: independent component analysis 20 
MEG: magnetoencephalography 21 
MLR: middle latency responses  22 
MMN: Mismatch negativity 23 
MNI: Montreal institute of Neurology 24 
MSR: magnetic shielded room 25 
OP1: first cytoarchitectonic subdivision of the parietal operculum  26 
S: Standards 27 
SARA: Scale for the Assessment and Rating of Ataxia 28 
SI: primary somatosensory cortex 29 
SII: secondary somatosensory cortex 30 
smMMN: somatosensory magnetic MMN 31 
sMMN: somatosensory MMN 32 
SSEPs: cortical somatosensory evoked potentials 33 
tDCS: transcranial direct current stimulation 34 
TERs: neocortical tactile evoked responses 35 
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Introduction 1 
 Friedreich ataxia (FRDA) is the most common form of recessive inherited ataxia in 2 
Caucasians (Ruano et al. 2014) with a prevalence of 3-4/100000 (Schulz et al. 2009). It is 3 
caused in most patients by homozygosity for a GAA1 trinucleotide repeat expansion in the 4 
first intron of the frataxin (FXN) gene (Campuzano et al. 1996), encoding the mitochondrial 5 
protein FXN. Expanded GAA1 repeats lead to FXN deficiency causing mitochondrial 6 
dysfunction and, ultimately, cell death (González-Cabo and Palau 2013). In humans, FXN 7 
mRNA is most abundant in tissues affected by FRDA (Pandolfo 2008), partly explaining their 8 
selective vulnerability. FRDA was initially described in 1863 by Nikolaus Friedreich as a 9 
spinal disorder characterized by an atrophy of the spinal posterior columns (Friedreich 1863). 10 
Loss of large primary sensory neurons in the dorsal root ganglia (DRGs), and consequently of 11 
large myelinated fibers in sensory nerves and in the posterior columns of the spinal cord is the 12 
pathological hallmark of FRDA. It is an early phenomenon, considered by some to be 13 
developmental more than degenerative (Mascalchi et al. 2017), though signs of active 14 
neuronal loss and inflammation persist in DRGs throughout life (Koeppen et al. 2016).	15 
Atrophy of Clarke column and loss of spinocerebellar fibers follow the loss of primary 16 
proprioceptive neurons in DRGs (Koeppen and Mazurkiewicz 2013). The cerebellum also 17 
develops intrinsic pathology affecting the dentate nucleus and consequently its efferent fibers 18 
in the superior cerebellar peduncle (Koeppen and Mazurkiewicz 2013), while cortical 19 
cerebellar atrophy is at most discrete (Koeppen and Mazurkiewicz 2013; Selvadurai et al. 20 
2016). Compared to DRG and spinal pathology, cerebellar involvement in FRDA is of later 21 
onset, after symptoms have appeared, being clearly degenerative in nature. Clinically, these 22 
structural lesions lead to a “tabetocerebellar gait” ataxic pattern combining afferent 23 
proprioceptive and cerebellar ataxia (for a review, see, e.g., Pandolfo, 2008).  24 
 5 
 The early, scarcely progressive, possibly developmental character of DRG pathology 1 
is supported by neurophysiological studies that show amplitude reduction of cortical 2 
somatosensory evoked potentials (SSEPs) correlating with the size of GAA1 triplet expansion 3 
and not with disease duration (Ouvrier et al. 1982; Said et al. 1986; Santoro et al. 1999). Still, 4 
part of the somatosensory impairments in FRDA could also be accounted by the progressive 5 
cerebellar degeneration. Indeed, in healthy subjects, the posterior lobe of the cerebellum and 6 
the ventral parts of the dentate nuclei contribute to sensory and perceptual processes (for 7 
reviews, see, e.g., Baumann et al., 2015; Leggio & Molinari, 2015), particularly in the 8 
selection of pertinent stimuli, attentional orientation and focusing. These processes require 9 
detecting changes in the temporal regularity (Moberget et al. 2008; Kotz et al. 2014) and in 10 
the physical features (Clark et al. 2000)of sensory stimuli.  11 
 The mismatch negativity (MMN) is the electromagnetic signal that reflects the early 12 
cortical response to a change in a sensory stimulus. It is elicited by rare stimuli (i.e., deviants) 13 
inserted into a sequence of repeated stimuli (i.e., standards) (for reviews, see, e.g.,Garrido, 14 
Kilner, Stephan, & Friston, 2009). MMN has been described for the auditory (aMMN) 15 
(Naatanen and Alho 1995) somatosensory (sMMN) (Kekoni et al. 1997) and visual (Czigler I, 16 
Balázs L 2002) modalities. Interestingly, two studies performed in patients with cerebellar 17 
disorders showed prominent sMMN alteration ipsilaterally to cerebellar hemispheric lesions, 18 
but normal pitch aMMN (Restuccia et al. 2007; Moberget et al. 2008). Furthermore, 19 
cerebellar transcranial direct current stimulation (tDCS) in healthy subjects modulates sMMN 20 
but not aMMN. These findings suggest a role of the cerebellum in somatosensory change 21 
detection compared to the auditory modality.  Previous functional neuroimaging studies 22 
identified the secondary somatosensory (SII) cortex as the main sMMN generator (Downar et 23 
al. 2000; Akatsuka et al. 2005; Naeije et al. 2016, 2017). Thus, the functional role of the 24 
 6 
cerebellum in somatosensory change detection might be exerted by affecting SII cortex 1 
activity.   2 
 To test this hypothesis, we compared somatosensory and auditory MMN responses in 3 
FRDA patients, where primary sensory and cerebellar pathology coexist. Besides 4 
investigating how these pathologies evolve and interact in FRDA, this study aimed at getting 5 
further insights into the neural network involved in sensory change detection, and in particular 6 
how the cerebellum differentially affects sMMN and aMMN. For that purpose, we used 7 
magnetoencephalography (MEG) to investigate in a large population of FRDA patients the 8 
cortical evoked magnetic fields (cEMFs) elicited by tactile and auditory change detection by 9 
comparison with matched healthy subjects. A prerequisite to the interpretation of MMN 10 
responses in FRDA patients was the characterization of cEMFs elicited by tactile and auditory 11 
stimuli at primary sensory cortices. Contrary to EEG used to detect SSEPs, MEG provides 12 
heightened sensitivity and signal-to-noise ratio for neocortical sources on the sides of sulci, 13 
such as the hand representations at primary somatosensory (SI) and SII cortices (Goldenholz 14 
et al. 2009; Hunold et al. 2016; Puce and Hamalainen 2017). Accordingly, by using MEG, we 15 
expected to detect cortical responses to tactile hand stimuli in a larger proportion of FRDA 16 
patients than in previous studies that used SSEPs, in which responses could only be recorded 17 
in 1/3 to 2/3 of FRDA patients (Jones et al. 1980; Pelosi et al. 1984; Vanasse et al. 1988; 18 
Santoro et al. 1999, 2000; Santiago-Perez et al. 2007). We also tested the specific hypothesis 19 
that the magnetic sMMN (smMMN) at SII cortex contralateral to the tactile stimulation would 20 
be altered in FRDA patients possibly due to the FRDA-related cerebellar involvement while 21 
the magnetic aMMN (amMMN) would not. We also assessed to what extent smMMN 22 
responses would correlate in FRDA patients with disease duration, GAA1 triplet expansion 23 
and patients’ clinical parameters. 24 
  25 
 7 
Materials and Methods 1 
Participants 2 
 Sixteen right-handed adults with genetically proven FRDA (10 females, six males, age 3 
27.8 ± 12.6 years) were included in this study. Of notice, one patient was heterozygous for a 4 
GAA1 repeat expansion and had a point mutation in the FXN gene. All patients were included 5 
in the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS, 6 
http://www.e-facts.eu/html/studies/project/concept) clinical study, which collects 7 
demographic, genetic, and prospective clinical data such as SARA scores. Handedness was 8 
defined, as in EFACTS, according to the patients’ report of their preferred hand for the use of 9 
objects in daily life tasks. Table 1 summarizes the patients’ clinical characteristics.  10 
 Nine patients (five females, age 35.8 ± 10.9 years, mean GAA1 621 ± 225, mean 11 
SARA 24 ±7.5) also accepted to undergo SSEPs recording using electrical stimulation of the 12 
right median nerve. Recording and analysis of SSEPs were done as in Santoro et al. (2000) 13 
except that, for comfort reasons, the two trials consisted of 256 epochs rather than 1000 14 
epochs. 15 
 As controls, we recruited 16 healthy right-handed adult subjects without any history of 16 
neurological or psychiatric disorder, who were matched to FRDA patients for age and sex (10 17 
females, six males, age 28 ± 13 years).  18 
 All participants provided written informed consent. The study was approved by the 19 
CUB-Hôpital Erasme Ethics Committee (Reference EudraCT/CCB: B406201317212). 20 
 21 
Experimental Paradigm  22 
 Participants underwent three experimental conditions: a unilateral somatosensory 23 
oddball paradigm, a monaural auditory oddball paradigm, and a five minutes resting-state 24 
period. They were instructed to gaze at a cross on the wall of the magnetically shielded room 25 
 8 
(MSR) during each condition. The order of the three conditions was randomized across 1 
participants. In those oddballs, participants were exposed to 600 stimuli in each modality of 2 
which 500 were standards and 100 deviants. 3 
 Figure 1 illustrates the oddball paradigms used to elicit the somatosensory and 4 
auditory brain responses.  5 
  In the tactile oddball paradigm, derived from (Naeije et al. 2016, 2017), stimuli were 6 
applied using a pneumatic stimulator, as described in (Wienbruch et al. 2006). Standards were 7 
applied to the right index fingertip (stimulated area: 1 cm2, intensity: 2 bars, duration: 50 ms), 8 
while deviants consisted in the simultaneous stimulation of the fingertip and the middle 9 
phalanx of the right index finger. Importantly, all FRDA patients felt the difference between 10 
standards and deviants during a preliminary test stimulation done outside the MSR. 11 
Pneumatic tactile stimuli were preferred to peripheral nerve electrical stimulation not only 12 
because they are more natural and not unpleasant, but also because electrical stimuli activate 13 
simultaneously a large number of fibers with different conduction velocities, bypassing 14 
peripheral mechanoreceptors as well as the distal part of peripheral nerves (Naeije et al. 15 
2017). Standards and deviants were applied on the same finger in order to recruit as much as 16 
possible common peripheral and cortical pathways (Naeije et al. 2017). Of note, the fact that 17 
more skin mechanoreceptors are stimulated by deviants than by standards is not of concern, as 18 
we previously showed that smMMN responses do not change if such standards and deviants 19 
are flipped (Naeije et al., 2016).  20 
 For the auditory oddball paradigm, derived from (Bekinschtein et al. 2009), stimuli 21 
consisted in audible tones (50 ms duration, 10 ms rise, 10 ms fall) of 540 Hz (standards) or 22 
600 Hz (deviants) that were presented in participants’ right hear using an Etymotic ER-3A 23 
(Etymotic Research Inc., Illinois, USA) earphone at a comfortable volume.  Participants wore 24 
 9 
Etymotic ER-3A earphones in both ears during the entire experiment to suppress auditory 1 
noise, particularly generated by the pneumatic stimulation.  2 
 For each oddball paradigm, blocks of five stimuli were applied with an inter-stimulus 3 
interval (ISI) of 500 ms. Each block comprised either four standards followed by a deviant 4 
(SSSSD, standard block) or five standards (SSSSS, deviant block). Each deviant within 5 
standard SSSSD blocks broke a sequence of four identical stimuli, hence leading to a local 6 
change expected to generate a MMN response (Bekinschtein et al. 2009; Wacongne et al. 7 
2011; Chennu et al. 2013; Naeije et al. 2016). One hundred and twenty blocks were 8 
administered in each oddball condition to participants with an inter-block interval (IBI) of 800 9 
ms. The first 20 blocks were always standard (SSSSD) blocks, whereas the subsequent 100 10 
blocks consisted of 20 deviant (SSSSS) blocks randomly intermingled among 80 standard 11 
(SSSSD) blocks, with the only constraint that two deviant blocks could not occur 12 
successively. Deviant (SSSSS) blocks were used to lower the predictability of deviant stimuli 13 
occurrence within standard (SSSSD) blocks as the cerebellum is thought to be involved in 14 
sensory change detection through predictions about upcoming sensory events. Furthermore, in 15 
this paradigm participants were asked to count the number of deviant (SSSSS) blocks, thereby 16 
limiting attentional fluctuations along the oddball paradigms.  17 
 The resting-state recording lasted five minutes, during which participants were 18 
instructed to relax, not to move and to gaze at a fixation point in the MSR to avoid any eye 19 
movements.  20 
Data Acquisition 21 
 Participants’ neuromagnetic activity was recorded using a whole-scalp-covering MEG 22 
device (Neuromag Vectorview, Elekta Oy, 12 FRDA patients, seven controls; Triux, MEGIN, 23 
four FRDA patients, nine controls; Helsinki, Finland), installed in a lightweight MSR 24 
(Maxshield, MEGIN, Helsinki, Finland)(De Tiège et al. 2008). The MEG sensor layout 25 
 10 
consisted in 102 sensor triplets, each comprising one magnetometer and two orthogonal 1 
planar gradiometers characterized by different patterns of spatial sensitivity to right beneath 2 
or nearby cortical sources. Four head-tracking coils monitored participants’ head position 3 
inside the MEG helmet. The location of the coils and at least 150 head-surface (on scalp, nose 4 
and face) points with respect to anatomical fiducials were determined with an electromagnetic 5 
tracker (Fastrak, Polhemus, Colchester, VT, USA). Eye movements and blinks were 6 
monitored with vertical and horizontal electrooculograms (EOGs). An electrocardiogam 7 
(ECG) was also recorded using bipolar electrodes placed below the clavicles. All signals were 8 
sampled at 1 kHz with online band-pass filter at 0.1–330 Hz. Subjects’ high-resolution 3D-T1 9 
cerebral magnetic resonance images (MRIs) were acquired on a 1.5 T MRI scanner (Intera, 10 
Philips, Netherlands). 11 
 12 
MEG data preprocessing  13 
 Continuous MEG data were first preprocessed off-line with the signal space separation 14 
(SSS) method to subtract external interferences and correct for head movements (Taulu et al. 15 
2005). Then, ocular and cardiac artifacts were suppressed using an independent component 16 
analysis (ICA). Specifically, the filtered data (off-line band-pass: 0.1-45 Hz) were divided 17 
into 1-s-long epochs. Epochs with large system artifacts were excluded automatically from 18 
the subsequent ICA on the basis of predefined amplitude thresholds (0.7 pT/cm for planar 19 
gradiometers and 3 pT for magnetometers). The ICA decomposition was then performed 20 
using the FastICA algorithm (dimension reduction to 30, nonlinearity tanh) on the remaining, 21 
temporally concatenated epochs (Vigário 1997). Artifactual components were identified using 22 
temporal correlations with EOG and ECG signals (correlation thresholds: 0.15) and visual 23 
inspection of their spatial topography (number of excluded artifactual components ranged 24 
 11 
from 2 to 5 across participants). Finally, the time series of those components were regressed 1 
out from the raw, continuous data. 2 
 The open source software Fieldtrip was then used for further preprocessing 3 
(Oostenveld et al. 2011). A common pipeline was applied to generate the evoked responses of 4 
interest, which included MEG data epoching (−200 ms to 600 ms post-stimulation onset), 5 
automatic epoch rejection (same thresholds as above), low-pass filtering (45 Hz), baseline 6 
correction (–150 ms to 0 ms post-stimulus onset), and epoch averaging. Epochs corresponding 7 
to standard stimuli and to local deviants were averaged separately.  8 
 Resting state data were similarly preprocessed and divided into epochs of same length 9 
(i.e., 800 ms), so as to provide surrogate MEG signals needed for the statistical assessment of 10 
cEMFs elicited by standards and deviants. 11 
 12 
Source reconstruction 13 
 Individual MRIs were first segmented using the Freesurfer software (Martinos Center 14 
for Biomedical Imaging, Massachusetts, USA). MEG and MRI coordinate systems were co-15 
registered manually using the three anatomical fiducial points for initial estimation and then 16 
refined with the head surface points. Then, a source grid (5 mm inter-source distance) built on 17 
Montreal Neurological Institute (MNI) brain was deformed onto each participant’s brain 18 
using a non-linear spatial deformation mapping MNI to participants’ brain (Ashburner et al. 19 
1997; Ashburner and Friston 1999)(SPM8, Welcome Trust Centre for Neuroimaging, 20 
London, UK). On this basis, the forward model was computed using the one-layer boundary 21 
element method implemented in the MNE-C suite (Gramfort et al. 2014) (Martinos Center for 22 
Biomedical Imaging, Massachusetts, USA). 23 
 Source-level distributed activity was then reconstructed for standard, deviant and 24 
resting-state epochs using dynamic statistical parametric mapping (dSPM,(Dale and Sereno 25 
 12 
1993). The sensor-space noise covariance was estimated from the baseline and the 1 
regularization parameter was set using the prior consistency condition derived in (Wens et al. 2 
2015). The source power time courses were defined as the Euclidian norm of the three 3 
components of each dipole. 4 
 At the individual level, this data processing and source reconstruction allowed us to 5 
determine the location, timing and amplitude of the corresponding cEMFs. 6 
 7 
Statistical assessments 8 
Individual level analyses in source space 9 
 First, the significance of source-projected cEMFs at primary sensory cortices elicited 10 
by standard stimuli in somatosensory and auditory oddballs was evaluated individually, both 11 
in FRDA patients and healthy subjects. To do so, we focused on the time interval 0–300 ms 12 
post-stimulus onset and investigated the difference between individual cEMFs and the 13 
analogous signal derived from resting-state epochs (matched for same epoch length and 14 
number) using a non-parametric permutation test. To deal with the issue of multiple spatio-15 
temporal comparisons (16102 sources × 300 time samples), we used a maximum-based 16 
unpaired, two-tailed statistic (Nichols and Holmes 2002) built as the maximum absolute 17 
difference over all sources and all considered time points. Its null distribution was generated 18 
from 1000 random permutations of the conditions (i.e., standard vs. resting-state). The 19 
significance threshold at p < 0.05 was then derived as the 95th percentile of this distribution. 20 
Source-projected cEMFs were deemed statistically significant whenever the maximum 21 
statistic exceeded this threshold. In that case, the timeframe of significance was identified as 22 
the periods during which the time course of the spatial maximum of differences between 23 
standards and resting-state epochs exceeded the above-mentioned threshold, and the spatial 24 
localization was obtained as supra-threshold activity within these timeframes. The latency and 25 
 13 
the amplitude of the peak of the first cortical response elicited by standards in somatosensory 1 
and auditory oddballs were then visually identified within the timeframe of significance for 2 
each FRDA patient and healthy subjects. The resulting latencies and maximum amplitudes 3 
were compared between FRDA patients and healthy subjects via classical unpaired, two-tailed 4 
Student’s t tests for each condition (i.e., standards in somatosensory and auditory oddballs). 5 
 We subsequently investigated the existence of differences between source-space 6 
cEMFs elicited by standards and deviants in somatosensory and auditory oddball paradigms 7 
for each FRDA patient and healthy subject. A similar non-parametric maximum-based 8 
permutation approach was used to that effect but here, random permutations mixed standard 9 
and deviant epochs in each participant and each modality (i.e., somatosensory and auditory 10 
oddballs). The location, latency and amplitude of mMMN responses were identified using a 11 
similar approach as describe above. 12 
 Finally, we examined in FRDA patients the possible relations between brain responses 13 
(the maximum amplitude of the first cortical responses elicited by standards in somatosensory 14 
and auditory oddballs as well as smMMN and amMMN responses) and patients’ 15 
characteristics (disease duration, size of GAA1 triplet expansion, and SARA score) using 16 
Spearman’s rank correlation. In FRDA patients lacking statistically significant standard, 17 
smMMN, or amMMN cortical response, we visually identified the maximum response 18 
amplitude at the mean location and latency of significant cortical response observed across 19 
the individual FRDA patients with significant cortical response.  20 
Group level analyses in source space 21 
 The existence of statistically significant difference between the cortical responses 22 
elicited by deviants and standards in both tactile and auditory modalities was also examined at 23 
the group level in FRDA patients and healthy subjects. The analysis was similar to that used 24 
 14 
to derive individual-level statistics. The only difference was that units being permuted were 1 
subjects’ averaged data in both conditions rather than epochs. 2 
 Differences in amMMN and smMMN between FRDA patients and matched healthy 3 
subjects were sought using the same statistical scheme. Of note, to avoid significant 4 
differences due to delayed responses in FRDA patients, we used a non-parametric approach to 5 
test if the latencies of the maximum group-level MMN response were different in healthy 6 
subjects and FA patients. To do so, for each of the two groups, the distribution of group-level 7 
maximum response timing was estimated using a resampling strategy (number of resamples: 8 
10.000), whereby this latency was obtained from the MMN derived using a random selection 9 
of 16 healthy subjects/FRDA patients with replacement. We, then, tested for a significant 10 
difference in the mean latency (i.e., difference in the two MMN peak timings) using a 11 
permutation test on these two distributions (number of random permutations of healthy 12 
subjects/FRDA patients label: 10.000). If there was a significant difference in MMN latencies 13 
between groups, the difference between group-level amMMN and smMMN in FRDA patients 14 
and healthy subjects was sought after temporal realignment on the timing of group-level 15 
maximum MMN response in each modality. 16 
Effects of MEG systems on acquired results 17 
In order to exclude a system (Vectorview vs. Triux) effect on the observed evoked responses, 18 
data from healthy subjects were split into one subgroup whose data was acquired with the 19 
Vectorview system (7 subjects) and another, with the Triux system (9 subjects). We, then, 20 
assessed the system effect by comparing their evoked responses for each sensor and time 21 
sample using a two-tailed unpaired t-test. Given the large number of comparisons, we 22 
estimated the number of comparisons involved as the product of the number of spatial degrees 23 
of freedom (about 80 after signal space separation) and of temporal degrees of freedom (as 24 
estimated on the basis of the largest frequency in the data, i.e., 45 Hz) and applied a 25 
 15 
Bonferoni correction to the t-tests at p<0.05 corrected. Furthermore, to preclude a potential 1 
effect induced in our source-level group comparisons by the two MEG system used that may 2 
have escaped the statistics of the sensor-space evoked response comparison, source-level 3 
statistical tests were re-run by introducing explicitly the MEG system type as a covariate of 4 
non-interest so as to eliminate the potential system effect. Specifically, we first regressed the 5 
system type out of the evoked responses and then rerun our maximum-based permutation tests 6 
 7 
8 
 16 
Results 1 
 2 
Figure 2 shows butterfly plots of the grand-averaged data for standard and deviant stimuli, 3 
and their difference (i.e., MMN) in each sensory modality and participants’ group. 4 
 5 
Evoked responses to standards in tactile and auditory paradigms 6 
 Figure 2 shows a butterfly plot of the grand averaged raw data of standard and deviant 7 
stimuli in each modality and groups. Figures 3 and 5 illustrate the latency and the amplitude 8 
of source-space standard-elicited tactile (Figure 3) and auditory (Figure 5) cEMFs at primary 9 
sensory cortices in FRDA patients and healthy subjects as well as the correlation of the 10 
maximum amplitude of those responses with the size of GAA1 triplet expansion in FRDA 11 
patients. 12 
 13 
Tactile evoked responses (Figure 3) 14 
 At the individual level, statistically significant somatosensory cEMFs were found for 15 
standards at SI cortex contralateral to stimulation (cSI) in all but one FRDA patients (mean ± 16 
SD MNI peak coordinates [-38.5 -24.2 47.3] ± [4.2 7.8 4.1] mm) and in all healthy subjects 17 
([-39.8 -25.2 47.3] ± [5.6 6.4 15.7] mm). Maximum significant cSI cortical responses had 18 
longer latencies and smaller amplitudes of peak response in FRDA patients than in healthy 19 
subjects (latency, 56.0 ± 20.3 ms vs. 30.3 ms ± 6.0, p < 0.001; dSPM amplitude, 0.29 ± 0.17 20 
vs. 0.51 ± 0.18 dSPM, p = 0.004). In FRDA patients, the maximum amplitude of cSI cortex 21 
response significantly correlated with the size of GAA1 repeat expansion (R = -0.74, p = 22 
0.003, Spearman correlation), but neither with disease duration (R = 0.13, p = 0.64), nor with 23 
the SARA score (R = -0.07, p = 0.80). 24 
Of note, a N20 response could be clearly identified in only two of the nine FRDA patients 25 
who underwent classical SSEP testing, with latencies of 26.1 ms and 27.65 ms, and 26 
 17 
amplitudes of 0.3 µV and 0.38 µV (normal N20 latency 19.6 ± 1.02 ms; normal N20 1 
amplitude 2.1 ± 0.9 µV). Importantly, in addition to the two subjects who displayed N20 2 
responses, six out of the seven patients who did not display clear N20 responses had 3 
significant cSI cortex responses in MEG recordings.  (Figure 4) 4 
 5 
Auditory evoked responses (Figure 5) 6 
 Statistically significant auditory cEMFs to unilateral standards were recorded at the 7 
contralateral (cAI) and ipsilateral (iAI) auditory cortices in all FRDA patients but one (cAI, [-8 
52.8 -24 5.8] ± [4.1 7.5 5.3] mm; iAI, [54.8 -16.9 3.6] ± [5.4 8.9 5.2] mm), and in all healthy 9 
subjects (cAI, [-50.4 -25.4 3.2] ± [3.7 9.0 9.7] mm; iAI, [56.3 -17.4 6.1] ± [1.8 6.5 3.0] mm). 10 
 Maximum significant cAI and iAI cortical responses had longer latencies in FRDA 11 
patients than in healthy subjects (cAI, 107 ± 23 ms vs. 87 ± 11 ms, p = 0.011; iAI, 115 ± 31 12 
ms vs. 96 ± 11 ms, p = 0.038), but there were no significant differences in dSPM amplitude 13 
(cAI, 0.55 ± 0.29 vs. 0.42 ± 0.23, p = 0.51; iAI, 0.5 ± 0.3 vs. 0.3 ± 0.12, p = 0.13). 14 
 In FRDA patients, the maximum amplitude of the cAI response to standards 15 
negatively correlated with the size of GAA1 repeat expansion (R = -0.56, p = 0.036), but 16 
neither with disease duration (R = 0.14, p = 0.64), nor with the SARA score (R = -0.34, p = 17 
0.23). Conversely, there was no correlation between the maximum amplitude of the iAI 18 
response to standards and the size of GAA1 repeat expansion (R = -0.3, p = 0.29), the SARA 19 
score (-0.15, p = 0.57) or disease duration (R = -0.3, p = 0.24). 20 
Early neocortical sensory change detection  21 
 Figures 6 and 7 illustrate smMMN (Figure 6) and amMMN (Figure 7) responses 22 
obtained in FRDA patients and in healthy subjects as well as the correlation of the maximum 23 
amplitude of smMMN responses with the size of GAA1 triplet expansion in FRDA patients.  24 
 25 
 18 
Early cortical somatosensory change detection  1 
 In 11/16 healthy subjects, a significant smMMN was recorded only at cSII cortex from 2 
83 ± 30 ms to 132 ± 28 ms post-deviant onset (peak difference [-43.0 -25.3 28.0] mm ± [4.6 3 
7.4 7.0] mm, dSPM amplitude difference 0.62 ±0.3). At the group level, a significant 4 
smMMN was found only at cSII cortex ([-46 -25 24] mm, amplitude: 0.5 dSPM unit) from 63 5 
to 139 ms post-deviant onset. 6 
 In 6/16 FRDA patients, a significant smMMN was also detected only at cSII cortex 7 
from 117 ± 41 ms to 151 ± 16.4 ms post-deviant onset ([-46.8 -16.2 16.7] mm ± [7.9 8.4 7.0] 8 
mm, 0.38 ± 0.21 dSPM unit). Patients with significant smMMN had a GAA1 of 650 ± 264 9 
triplet expansions, an age of onset of 15.6 ± 7.6, a disease duration of 20.1 ± 9.7 and a mean 10 
SARA score of 24.2 ± 7.3. Of note, no significant difference was found, with a T-test, 11 
between FRDA patients with and without significant smMMN in their size of GAA1 triplet 12 
expansion (650 ± 264 vs. 771± 166, p = 0.13), age of onset (15.6 y ± 7.6 vs. 11.8 y ± 4.3, p = 13 
0.11), disease duration (20.1 y ± 9.7 vs. 15.6 ± 10.2, p = 0.18) and mean SARA score (24.2 ± 14 
7.3 vs. 25.6 ± 6.8, p = 0.35).  15 
At the group level, a significant smMMN was found only at cSII cortex ([-49 -19 19] mm, 0.2 16 
dSPM unit) from 114 to 170 ms post-deviant onset.  17 
 The resampling analysis showed that smMMN peak occurred significantly later in 18 
FRDA patients than in healthy subjects (mean increased latency in FRDA patients: 40 ms; p < 19 
0,001). Therefore, smMMN responses were temporally realigned based on the timing of the 20 
maximum cSII cortex response to allow proper source space comparison between FRDA 21 
patients and healthy subjects. A significantly higher smMMN response at cSII cortex ([-40 -22 
25 30] mm, dSPM amplitude difference 0.4) was observed in healthy subjects compared with 23 
FRDA patients from 73 to 122 ms post-deviant onset.  24 
 19 
 In FRDA patients, the smMMN amplitude at cSII cortex correlated significantly with 1 
the size of GAA1 repeat expansion (n = 15; R = -0.65, p = 0.0082) but neither with disease 2 
duration (n = 16; R = 0.23, p = 0.40), nor with the SARA score (n = 16; R = -0.18, p = 0.51). 3 
 4 
Early neocortical auditory change detection  5 
 In 10/16 healthy subjects, a significant amMMN was detected 161 ± 33 ms to 190 ± 6 
43 ms post-deviant onset at cAI ([-49.8 -14.2 4.3] mm ± [6.8 8.7 7.8] mm, 0.42 ± 0.18 dSPM 7 
unit) and iAI ([54.3 -19.7 3.8] mm ± [3.4 18.5 2.2] mm, 0.4 ± 0.1 dSPM unit) cortices. At the 8 
group level, a significant amMMN response was found only at the cAI cortex ([-40 -22 9] 9 
mm, 0.11 dSPM unit) from 162 to 172 ms after deviants onset.  10 
 In 11/16 FRDA patients, a significant amMMN was detected 164 ± 26 ms to 189 ± 23 11 
ms post-deviant onset at cAI ([-46.7 -22.5 7.7] mm ± [5.3 4.8 1.8] mm, 0.44 ± 0.18 dSPM 12 
unit) and iAI ([53.2 -16.9 2.4] mm ± [5.8 8.0 3.9] mm, 0.34 ±0.1 dSPM unit) cortices. At the 13 
group level, a significant amMMN was also found only at cAI cortex ([-43 -19 6] mm, 0.2 14 
dSPM unit) from 150 to 180 ms after deviant onset. 15 
 The resampling analysis disclosed no latency differences in amMMN between FRDA 16 
and healthy subjects. Therefore, no temporal realignment of amMMN responses was 17 
performed to search for differences in amMMN response amplitude. No difference in 18 
amMMN amplitude was found between FRDA patients and healthy subjects. 19 
 20 
Effect of the MEG systems on evoked magnetic fields 21 
No significant difference was found between healthy subjects’ sensor-level evoked response 22 
obtained with the two MEG systems. At the source-level, after regressing out the potential 23 
effects of the MEG system from the data, results were quantitatively similar and none of our 24 
conclusions affected, excluding that the results are driven by the type of MEG system used.  25 
 20 
Discussion 1 
 2 
 This MEG study conducted in a large population of genetically proven FRDA patients 3 
demonstrates that (i) tactile and auditory standard stimuli elicit robust but abnormal responses 4 
at cSI (delayed and reduced in amplitude) and AI (only delayed) cortices respectively in 5 
FRDA patients compared with healthy controls, (ii) early neocortical sensory change 6 
detection is altered in FRDA-patients for the tactile modality but not for the auditory 7 
modality, and (iii) the amplitude of the smMMN response at cSII cortex correlates with the 8 
size of GAA1 repeat expansion but not with disease duration nor severity. Taken together, 9 
these data bring empirical evidence supporting the contribution of cerebellar pathways in 10 
smMMN genesis at cSII cortex. 11 
 12 
Neuromagnetic evoked responses to standards and deviants in healthy subjects  13 
 Brain responses recorded in healthy controls peaked at timings and locations 14 
compatible with previous reports. In all healthy subjects, standard tactile stimuli elicited a 15 
significant cortical response at the post-central gyrus contralateral to the stimulation, 16 
corresponding to SI cortex in terms of MNI coordinates (Pleger et al. 2003; Eickhoff et al. 17 
2005) and latency (Mauguiere et al. 1997; Hari and Forss 1999; Papadelis et al. 2011; 18 
Avanzini et al. 2016). Similarly, standard auditory stimuli elicited significant cortical 19 
responses typical of bilateral AI cortex in terms of MNI coordinates (Rademacher et al. 2001) 20 
and timing (Virtanen et al. 1998). Significant smMMN and amMMN responses were found in 21 
two-third of healthy subjects, which corresponds to the rate reported at the subject level in 22 
previous studies on smMMN (Naeije et al. 2016) and amMMN (Faugeras et al. 2012; King et 23 
al. 2013; Recasens and Uhlhaas 2017). The cortical generator of the smMMN identified using 24 
distributed source modeling was located at the first cytoarchitectonic subdivision of the 25 
parietal operculum (OP1) as described by Eickhoff’s probabilistic maps (Eickhoff et al. 2006) 26 
 21 
with regards to right hand somatotopy (Eickhoff et al., 2007). The finding of bilateral AI 1 
cortical generators of the amMMN at individual level is also in agreement with previous 2 
studies (Hari et al. 1992; Alho et al. 1998; Wacongne et al. 2011). However, at the group 3 
level, amMMN was only significant over the left AI cortex, which is in agreement with the 4 
fact that in mono-aural auditory oddballs, the amplitude of the aMMN is typically higher on 5 
the contralateral side to the stimulation (Chennu et al. 2013; Phillips et al. 2015, 2016). 6 
Finally, the timing of smMMN and amMMN responses was in agreement with previous 7 
reports (Garrido et al. 2009; Naatanen et al. 2011; Naeije et al. 2016, 2017). 8 
 9 
Neuromagnetic evoked responses to tactile standard stimuli and SSEPs in FRDA patients 10 
 Results of the present study suggest that MEG is more sensitive than SSEPs, as 6/7 11 
FRDA patients who did not display a N20 potential on SSEPs had significant magnetic cSI 12 
cortical responses to tactile standard stimuli. In previous reports, SSEPs could not be recorded 13 
in 33 to 68% of FRDA patients (Jones et al. 1980; Pelosi et al. 1984; Vanasse et al. 1988; 14 
Santoro et al. 1999, 2000; Santiago-Perez et al. 2007). It is intriguing how the frequent lack of 15 
recordable SSEPs in FRDA patients contrasts with their almost normal conscious perception 16 
of touch, even if their proprioception is altered (Saunders., 1913). In line with this 17 
observation, all patients were able to perceive and discriminate the different tactile stimuli 18 
(i.e., standards and deviants), which, along with the fact that neuromagnetic cSI cortex 19 
responses were recorded using 500 tactile standard stimuli in all but one FRDA patients, 20 
suggests that traditional SSEPs are probably less effective to assess the somatosensory system 21 
function in FRDA patients than MEG. The better sensitivity of MEG may be due to various 22 
and non-exclusive factors: higher sensors number  (306 sensors for MEG vs. eight scalp 23 
electrodes for SSEP), better signal to noise ratio for focal neocortical sources and heightened 24 
sensitivity to tangential neocortical sources such as area 3b of SI cortex (Goldenholz et al. 25 
 22 
2009) that are the primary cortical area for tactile processing (Keysers et al. 2010). 1 
Furthermore, in this study, we used pneumatic tactile stimuli that may recruit smaller caliber, 2 
less affected nerve fibers than electrical stimuli (Forss et al. 1994). Overall, our results 3 
indicate that MEG is a sensitive tool to study cortical sensory processing in diseases affecting 4 
the afferent sensory pathways such as FRDA.  5 
 FRDA patients displayed longer latencies and smaller amplitudes than control subjects 6 
for the maximal response elicited by tactile standard stimuli at cSI cortex. Increased latency 7 
of cSI cortex responses elicited by tactile stimuli is easily explained by the selective loss of 8 
large-size fast-conducting primary somatosensory neurons in the DRGs, along with their 9 
peripheral and central axonal branches in sensory nerves and in the posterior columns of the 10 
spinal cord (Hughes et al. 1968; Zouari et al. 1998; Santoro et al. 1999; Santiago-Perez et al. 11 
2007). Prolonged somatosensory central conduction time is well described in various diseases 12 
affecting the posterior columns of the spinal cord, such as multiple sclerosis (Ganes 1980), 13 
vitamin B12 deficiency (Zegers de Beyl et al. 1988), stroke  (Tinazzi and Mauguiere 1995) 14 
and medullary compression (Miyoshi and Kimura 1996), in addition to FRDA (Santiago-15 
Perez et al. 2007). The decrease in cSI cortex responses amplitude to tactile standard stimuli 16 
might be due to sensory neuron loss, but also to cerebellar pathology. Indeed, patients with 17 
unilateral cerebellar lesions (Restuccia et al. 2001)have smaller SI cortex responses to tactile 18 
stimuli on the ipsilateral hand to the cerebellar lesions and, in animal studies, induced 19 
cerebellar lesions lead to altered SI cortex responses (Kolodziejak et al. 2000). However, our 20 
results suggest that afferent pathology is mainly responsible for the loss of amplitude of SI 21 
cortex responses in FRDA patients. Indeed, as in a previous SSEPs study (Santoro et al. 22 
2000), the maximum amplitude of tactile cEMFs at cSI cortex correlated with the size of 23 
GAA1 repeat expansion, but not with the SARA score, nor with the disease duration. 24 
Cerebellar degeneration progressively occurs along the course of the disease in FRDA 25 
 23 
(Koeppen and Mazurkiewicz 2013; Silva et al. 2013; Koeppen et al. 2016; Rezende et al. 1 
2016). So, a decrease in the amplitude of the cSI cortex response due to cerebellar 2 
degeneration should correlate with the SARA score that mainly reflects cerebellar progressive 3 
structural and functional alterations (Akhlaghi et al. 2011; Silva et al. 2013; Selvadurai et al. 4 
2016) or disease duration, which was not the case. The observed correlation with the size of 5 
GAA1 triplet expansion instead suggests that the reduction in cSI cortex responses mostly 6 
depends on lemniscal pathway atrophy, already present at disease onset (Said et al. 1986; 7 
Santoro et al. 1999), mostly developmental (Ouvrier et al. 1982; Santoro et al. 1999), and 8 
whose extent is mostly determined by the severity of the trinucleotide repeat expansion.  9 
 10 
Neuromagnetic evoked responses to auditory standard stimuli in FRDA patients  11 
  Auditory perception is affected in FRDA patients at all levels of processing, from 12 
brainstem to early and late cortical sound/speech processing (Al-Azzawi and Mirza 2004; 13 
Rance et al. 2008, 2012). Yet, most studies in FRDA concentrated on brainstem auditory 14 
evoked potentials (BAEPs) and consistently showed that they are either absent or delayed 15 
(Pedersen and Trojaborg 1981; Taylor et al. 1982; Jabbari et al. 1983; Taylor 1983; Amantini 16 
et al. 1984; Campanella et al. 1984; Ell et al. 1984; De Pablos et al. 1991; Caruso et al. 1992). 17 
Cortically generated middle latency responses (MLR) (Onitsuka et al. 2003) and the more 18 
prominent long latency responses (LLR) (Virtanen et al. 1998) have been seldom studied in 19 
FRDA and, to the best of our knowledge, not since genetic testing became widely available. 20 
In clinically diagnosed FRDA patients, MLR and LLR responses were found to be delayed or 21 
absent (Shanon et al. 1981; Taylor et al. 1982; Amantini et al. 1984). In the present study, 22 
auditory cortical LLR elicited by auditory standard stimuli were present in all but one FRDA 23 
patients but were significantly delayed compared with healthy controls while their maximum 24 
amplitude was not different. The maximal amplitude of cAI cortex evoked responses to 25 
 24 
auditory standard stimuli negatively correlated with the size of GAA1 repeat expansion but 1 
not with the SARA score nor the disease duration (Satya-Murti et al. 1980; Santoro et al. 2 
1999).  3 
  Taken together, these observations support the view that both somatosensory and 4 
auditory pathways are affected early in the disease, in a genetically determined fashion that 5 
does not substantially evolve with disease progression. 6 
 7 
Early tactile change detection is impaired in FRDA and correlates with the size of GAA1 8 
triplet repeat expansion  9 
  Only 37% of FRDA patients displayed significant smMMN at cSII cortex, compared 10 
to 69% of healthy controls, and with smaller amplitude. A first explanation for the lower 11 
smMMN amplitude could be the loss of somatosensory afferences, as shown by lower cSI 12 
cortex responses to tactile standard stimuli. However, while responses at cSI and cSII cortices 13 
are related, their relation is complex and not strictly hierarchical, with parallel rather than 14 
serial processing of somatosensory stimuli (Karhu and Tesche 1999; Simoes et al. 2002; Gao 15 
et al. 2015). In a previous MEG study, pneumatic tactile stimuli applied to the proximal 16 
phalange of the middle finger elicited cSI cortex responses of at least 44% of the magnitude 17 
of those elicited by electrical median nerve stimulation slightly above motor threshold (Forss 18 
et al. 1994). However, in that study, cSII cortex responses were comparable between 19 
pneumatic and electrical stimuli, indicating that the magnitude of cSII cortex responses 20 
neither depends directly on the amount of stimulated afferent fibers, nor on the amplitude of 21 
the cSI cortex response (Forss et al. 1994). Indeed, the amplitude of cSII cortex responses is 22 
more influenced by the stimulus rate than stimulus intensity (Wikstrom et al. 1996; Naeije et 23 
al. 2017). Additionally, cSII cortex responses are well described in the absence of any cSI 24 
cortex response, like in off-responses (Yamashiro et al. 2008; Otsuru et al. 2011) and 25 
 25 
omission paradigms (Yamashiro et al. 2008, 2009; Naeije et al. 2017; Andersen and 1 
Lundqvist 2019). Finally, cSII cortex responses were similar in patients with reduced cSI 2 
cortex responses due to thalamic lesions compared with healthy subjects (Taskin et al. 2006) 3 
and in a primate models in which the inactivation of cSI cortex by cooling did not lead to 4 
subsequent cSII disappearance  arguing for parallel processing of tactile stimuli at cSI and 5 
cSII (Zhang et al. 1996). Therefore, the 40% mean reduction in magnitude of cSI cortex 6 
responses to tactile standard stimuli in all but one of our FRDA patients should not per se lead 7 
to reduced or absent cSII cortex responses. If afferent loss cannot convincingly explain 8 
reduced smMMN at cSII cortex in FRDA, cerebellar impairment of tactile processing might 9 
be involved. In this regard, our findings in FRDA patients parallel observations in healthy 10 
subjects who underwent cerebellar inhibition by tDCS and showed reduced sMMN responses 11 
(Chen et al. 2014), and in patients with unilateral cerebellar lesions who displayed almost no 12 
sMMN response after the presentation of deviant somatosensory stimuli on the hand 13 
ipsilateral to the affected cerebellar hemisphere (Restuccia et al. 2007). The use of unilateral 14 
stimuli in our study could have biased the results if cerebellar and afferent disorders in FRDA 15 
were asymmetrical. However, symptoms in FRDA are comparable and highly correlated 16 
between right and left hands on clinical scales. Furthermore, alterations on structural and 17 
functional neuroimaging as well as on pathology are typically symmetrical(Dürr et al. 1996; 18 
Subramony et al. 2005; Akhlaghi et al. 2011; Koeppen and Mazurkiewicz 2013; Zalesky et al. 19 
2014; Vavla et al. 2018). These findings therefore render a laterality bias in our results 20 
unlikely. By contrast, the amMMN was similar in healthy subjects and in FRDA patients. 21 
This lack of difference in amMMN responses parallels previous work on healthy subjects 22 
where cerebellar inhibition by tDCS did not alter aMMN responses (Chen et al. 2014) ), and 23 
studies on acquired and degenerative cerebellar lesions where patients had preserved pitch 24 
aMMN (Restuccia et al. 2007; Moberget et al. 2008). In FRDA patients, tactile change 25 
 26 
detection alterations negatively correlated with the size of GAA1 triplet expansion. This 1 
suggests the involvement of an afferent cerebellar pathways impairment due to diminished 2 
input from atrophied spinocerebellar and cuneocerebellar tracts that would result from 3 
primary somatosensory neurons and dorsal column pathology through trans-neuronal 4 
ascending degeneration (i.e., degeneration of spinocerebellar and cuneocerebellar tracts 5 
neurons due to a lack of input from first-order somatosensory neurons (Koeppen and 6 
Mazurkiewicz 2013). Indeed, lack of correlation with the SARA or disease duration indicates 7 
that alteration of efferent cerebellar pathways due to dentate pathology is less likely 8 
contributing to altered tactile change detection at cSII cortex (Silva et al. 2013). Still, a role of 9 
the indirect afferent pathway due to impaired cortico-ponto-cerebellar tracts also cannot be 10 
totally excluded.  11 
 12 
Conclusions 13 
This study demonstrates that, in FRDA, tactile evoked responses are delayed and reduced in 14 
amplitude at cSI cortex while auditory evoked responses are only delayed at AI cortices. 15 
Furthermore, it shows that smMMN responses at cSII cortex are impaired in FRDA patients 16 
while amMMN responses are preserved. Maximal amplitudes of tactile evoked, auditory 17 
evoked and smMMN responses do correlate with the genotype but not with clinical 18 
parameters. Overall, this study demonstrates a distinctive effect of FRDA pathology on 19 
somatosensory and auditory systems, as previously reported in patients with cerebellar 20 
disorders.  21 
 22 
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Tables and Figures 1 
 2 
Table 1. Clinical characteristics of the 15 FRDA patients with GAA1 triplet expansion 3 
Characteristics of FRDA participants (mean ± SD). GAA1: number of GAA1 triplet 4 
expansion on the shortest allele; SARA: score on the Scale for the Assessment and Rating of 5 
Ataxia. R= right / L= left. * Sub-Items of the SARA score rated between 0 (no deficit) to 4 6 
(impossible to perform the task). Of note, all patients performed either similarly with both 7 
hands or better with the dominant hand, and difference between hands never exceeded 1 8 
point. TER: tactile evoked response. cSI: contralateral primary somatosensory cortex. cSII: 9 
contralateral secondary somatosensory cortex.  10 
Age (Years) 27.8 ± 12.6s 
GAA1 706 ± 206 
Age of onset (Year) 12.4 ± 6.2 
Disease duration (Years) 15.4 ± 10.1 
SARA score 22.3 ± 7.5 
Upper-limb function 
   Finger Chase* (R/L) 
   Nose-Finger Test* (R/L) 
   Fast alternating hand movements* (R/L) 
   Nine-Hole Peg Test (seconds, R/L) 
   Tactile discrimination present (n,%)   
 
1.69±0.91/1.81±0.94 
1.44±1.27/1.93±1.14 
2.56±0.60/2.87±0.48 
85.4±42.3/112.2±64.6 
15 (100%) 
Tactile evoked responses 
   TER at cSI (n, mean latency ±SD, mean 
amplitude ±SD) 
   smMMN at cSII (n, mean latency ±SD, 
mean amplitude ±SD) 
 
15/15, 56±20.3 msec, 0.28 ± 
0.16 dSPM Units 
6/15, 134± 28.7 msec 0.37 ± 
0.16 dSPM Units 
  11 
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 1 
Figure 1 2 
Sensory oddball paradigm used in this study. Blocks of five stimuli either comprised four 3 
Standard (S) stimuli followed by a Deviant (D) stimulus (SSSSD blocks) or 5 Standard 4 
stimuli (SSSSS blocks). Each Deviant stimulus in SSSSD blocks (local deviation) broke a 5 
sequence of four identical stimuli, thereby eliciting a MMN response.    6 
 41 
 1 
Figure 2 2 
Butterfly plots (planar gradiometers) of the grand averaged sensor-level responses elicited by 3 
standards (upper line) and deviants (middle line) as well as of the mismatch negativity 4 
(MMN, bottom line) response for each modality and group. Each line in the butterfly plots 5 
represents the signal of one of the 204 planar gradiometers.   6 
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 1 
Figure 3 2 
Somatosensory evoked responses elicited by standards. Left. Averaged amplitude and latency 3 
in FRDA patients (black histogram) and healthy subjects (white histogram) of the first peak of 4 
somatosensory response at left primary cSI cortex. * = statistical difference with p < 0.001. 5 
Right. Spearman correlation plot between FRDA patients’ individual amplitude of cSI cortex 6 
response and the number of GAA1 triplet expansion on the shortest allele (nGAA1).   7 
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 1 
Figure 4 2 
SSEPS raw recordings in each of nine FRDA patients who underwent the investigation. 3 
Each line corresponds to an electrode. Erb stands for Erb’s point electrode, Na and Np 4 
for neck anterior and posterior electrodes, P3 and P4 for left and right parietal 5 
electrodes and A1 for left ear electrode.   6 
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Figure 5 2 
Auditory evoked responses elicited by standards. Top,Left. Averaged latency in FRDA 3 
patients (black histogram) and healthy subjects (white histogram) of the first peak of auditory 4 
response at left (cAI) and right (iAI) AI cortices. * = statistical difference with p < 0.001. 5 
Right. Spearman correlation plot between FRDA patients’ individual latency at cAI cortex. 6 
Bottom,Left. Averaged amplitude of the first peak of auditory response at cAI and iAI 7 
cortices. Right. Spearman correlation plot between FRDA patients’ individual amplitude at 8 
cAI cortex and the number of GAA1 triplet expansion on the shortest allele (nGAA1).   9 
 45 
 1 
Figure 6.  2 
Somatosensory mismatch negativity (smMMN) responses. A. Location and amplitude of 3 
statistically significant smMMN in healthy controls at SII cortex (MNI coordinates: [-46 -25 4 
24] mm) at 63–139 ms post deviant stimuli. B. Location and amplitude of statistically 5 
significant smMMN in FRDA patients above cSII cortex ([-49 -19 19] mm) at 114–170 ms 6 
post deviant stimuli. C. Location and amplitude of statistically significant difference in 7 
smMMN responses between healthy subjects and FRDA patients at cSII cortex after smMMN 8 
group level maximum peak temporal realignment (MNI coordinates: [-40 -25 30] mm). D. 9 
Spearman correlation plot between FRDA patients’ individual smMMN amplitude at cSII 10 
cortex and the number of GAA1 triplet expansion on the shortest allele (nGAA1).  11 
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 1 
Figure 7. 2 
Auditory mismatch negativity (amMMN) responses. A. Location and amplitude of 3 
statistically significant amMMN responses in healthy subjects above left AI cortex (MNI 4 
coordinates: [-40 -22 9] mm) at 162–172ms post deviant stimulus. B. Location and amplitude 5 
of statistically significant amMMN in FRDA patients above left AI cortex (MNI coordinates: 6 
[-43 -19 6] mm) at 150–180 ms post-deviant stimulus. 7 
 8 
